Peregrine Pharmaceuticals (NASDAQ:PPHM) Investor Files Lawsuit over Executive Compensation
An investor who holds shares of Peregrine Pharmaceuticals (NASDAQ:PPHM) filed a lawsuit against directors of Peregrine Pharmaceuticals in connection with allegedly excessive compensation.
View full press release